These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10933368)

  • 41. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.
    Nul DR; Doval HC; Grancelli HO; Varini SD; Soifer S; Perrone SV; Prieto N; Scapin O
    J Am Coll Cardiol; 1997 May; 29(6):1199-205. PubMed ID: 9137213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.
    Konstam V; Salem D; Pouleur H; Kostis J; Gorkin L; Shumaker S; Mottard I; Woods P; Konstam MA; Yusuf S
    Am J Cardiol; 1996 Oct; 78(8):890-5. PubMed ID: 8888661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
    Zhan H; Tse HF; Cao JM; Lau CP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.
    Gottdiener JS; Arnold AM; Aurigemma GP; Polak JF; Tracy RP; Kitzman DW; Gardin JM; Rutledge JE; Boineau RC
    J Am Coll Cardiol; 2000 May; 35(6):1628-37. PubMed ID: 10807470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
    Køber L; Torp-Pedersen C; Jørgensen S; Eliasen P; Camm AJ
    Am J Cardiol; 1998 Jun; 81(11):1292-7. PubMed ID: 9631965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance and management of arrhythmias in the heart failure patient.
    Greene HL
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I13-21. PubMed ID: 1395210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.
    Cygankiewicz I; Zareba W; Vazquez R; Vallverdu M; Gonzalez-Juanatey JR; Valdes M; Almendral J; Cinca J; Caminal P; de Luna AB;
    Heart Rhythm; 2008 Aug; 5(8):1095-1102. PubMed ID: 18675217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
    Kleber FX; Doering W
    Herz; 1991 Sep; 16 Spec No 1():283-93. PubMed ID: 1820294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure.
    de Groote P; Millaire A; Foucher-Hossein C; Nugue O; Marchandise X; Ducloux G; Lablanche JM
    J Am Coll Cardiol; 1998 Oct; 32(4):948-54. PubMed ID: 9768716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Cardiol; 2004 Jan; 93(1):59-63. PubMed ID: 14697467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.
    Grigioni F; Barbieri A; Russo A; Reggianini L; Bonatti S; Potena L; Fabbri F; Coccolo F; Magnani G; Bursi F; Magelli C; Modena MG; Branzi A
    J Heart Lung Transplant; 2006 Jun; 25(6):648-52. PubMed ID: 16730570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.
    Stellbrink C; Auricchio A; Diem B; Breithardt OA; Kloss M; Schöndube FA; Klein H; Messmer BJ; Hanrath P
    Am J Cardiol; 1999 Mar; 83(5B):143D-150D. PubMed ID: 10089857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators.
    Singh SN; Fisher SG; Carson PE; Fletcher RD
    J Am Coll Cardiol; 1998 Oct; 32(4):942-7. PubMed ID: 9768715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.